Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Bought by Millennium Management LLC

Millennium Management LLC boosted its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 27.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,087 shares of the medical instruments supplier's stock after acquiring an additional 6,975 shares during the quarter. Millennium Management LLC owned 0.95% of Utah Medical Products worth $1,972,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bard Associates Inc. increased its position in shares of Utah Medical Products by 1.3% during the fourth quarter. Bard Associates Inc. now owns 20,030 shares of the medical instruments supplier's stock worth $1,237,000 after acquiring an additional 249 shares during the period. Tower Research Capital LLC TRC increased its holdings in Utah Medical Products by 172.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock worth $32,000 after purchasing an additional 328 shares during the period. Wells Fargo & Company MN raised its position in Utah Medical Products by 24.9% during the 4th quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock valued at $118,000 after purchasing an additional 384 shares in the last quarter. Golden State Wealth Management LLC bought a new stake in Utah Medical Products during the 4th quarter valued at $31,000. Finally, Bessemer Group Inc. purchased a new stake in shares of Utah Medical Products in the 4th quarter worth $31,000. Institutional investors own 69.60% of the company's stock.

Utah Medical Products Price Performance

Shares of UTMD stock traded up $0.12 during mid-day trading on Friday, hitting $56.16. The stock had a trading volume of 11,817 shares, compared to its average volume of 19,535. Utah Medical Products, Inc. has a 12-month low of $51.26 and a 12-month high of $77.33. The firm has a market capitalization of $182.41 million, a P/E ratio of 14.22 and a beta of 0.30. The firm's 50-day moving average is $53.84 and its two-hundred day moving average is $58.60.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%. The business had revenue of $9.71 million during the quarter.

Utah Medical Products Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 3rd. Shareholders of record on Monday, June 16th will be issued a $0.305 dividend. This represents a $1.22 annualized dividend and a dividend yield of 2.17%. The ex-dividend date of this dividend is Monday, June 16th. Utah Medical Products's dividend payout ratio is 32.28%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.